Here are five highlights:
1. The VRS system is intended to help patients suffering from glenoid vault/socket extreme bone loss.
2. The technology represents the first patient-matched glenoid implant commercially available.
3. Drs. Mallo and Schrank serve as co-chiefs of the shoulder service at St. Charles Orthopedics in East Setauket, N.Y.
4. Dr. Mallo completed a shoulder reconstruction and arthroscopy fellowship at Harvard University/The Boston Shoulder Institute.
5. Dr. Schrank completed a sports medicine fellowship at Kerlan-Jobe Orthopaedic Clinic in Los Angeles.
More articles on devices:
Stryker, Zimmer Biomet, SeaSpine & more: 24 device company key notes
North America dominates pedicle screw systems market: 3 observations
SeaSpine ranks 3rd among top NASDAQ medical device stocks for first half of 2017 — 5 insights
